UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Bread Financial
BFH
$4.38B
| $3.93M | ﹤0.01% |
106,156
-24,729
| -19% | -$1.26M |
|
1302
BellRing Brands
BRBR
$1.34B
| $3.93M | ﹤0.01% |
158,018
+37,208
| +31% | +$910K |
|
1303
Simply Good Foods
SMPL
$982M
| $3.93M | ﹤0.01% |
104,099
+1,526
| +1% | +$60.5K |
|
|
DEN
1304
DELISTED
Denbury Inc.
DEN
| $3.93M | ﹤0.01% |
65,492
-2,457
| -4% | -$175K |
|
1305
AdaptHealth
AHCO
$759M
| $3.91M | ﹤0.01% |
216,659
-78,011
| -26% | -$1.27M |
|
1306
Cytokinetics
CYTK
$10.4B
| $3.91M | ﹤0.01% |
99,450
+5,807
| +6% | +$234K |
|
1307
Corcept Therapeutics
CORT
$12B
| $3.9M | ﹤0.01% |
163,948
-4,265
| -3% | -$92.9K |
|
|
ETRN
1308
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $3.89M | ﹤0.01% |
610,870
+27,808
| +5% | +$215K |
|
1309
Adient
ADNT
$1.5B
| $3.87M | ﹤0.01% |
130,727
-4,918
| -4% | -$165K |
|
1310
Sensient Technologies
SXT
$5.53B
| $3.87M | ﹤0.01% |
48,006
+1,076
| +2% | +$89.2K |
|
1311
Arrowhead Research
ARWR
$12.4B
| $3.86M | ﹤0.01% |
109,725
-4,161
| -4% | -$157K |
|
1312
CNX Resources
CNX
$5.2B
| $3.84M | ﹤0.01% |
233,230
-4,268
| -2% | -$87.4K |
|
1313
First Bancorp
FBP
$4.38B
| $3.83M | ﹤0.01% |
296,802
+906
| +0.3% | +$12.4K |
|
1314
Kymera Therapeutics
KYMR
$8.94B
| $3.83M | ﹤0.01% |
194,324
-235,919
| -55% | -$5.51M |
|
|
EDR
1315
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $3.82M | ﹤0.01% |
185,858
-47,442
| -20% | -$1.08M |
|
1316
Diodes
DIOD
$4.84B
| $3.82M | ﹤0.01% |
59,156
+332
| +0.6% | +$24.2K |
|
1317
Beyond Meat
BYND
$277M
| $3.8M | ﹤0.01% |
158,879
-7,702
| -5% | -$246K |
|
|
CHCT
1318
Community Healthcare Trust
CHCT
$454M
| $3.8M | ﹤0.01% |
105,029
-1,645
| -2% | -$61.6K |
|
1319
Sprout Social
SPT
$621M
| $3.8M | ﹤0.01% |
65,489
+7,666
| +13% | +$446K |
|
|
LTHM
1320
DELISTED
Livent Corporation
LTHM
| $3.8M | ﹤0.01% |
167,364
-3,076
| -2% | -$79.2K |
|
1321
Outfront Media
OUT
$5.5B
| $3.8M | ﹤0.01% |
227,480
-4,624
| -2% | -$101K |
|
1322
Transocean
RIG
$5.82B
| $3.79M | ﹤0.01% |
1,138,319
+170,705
| +18% | +$692K |
|
1323
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $3.74M | ﹤0.01% |
104,472
-105,944
| -50% | -$4.25M |
|
|
AHRT
1324
AH Realty Trust
AHRT
$517M
| $3.73M | ﹤0.01% |
290,363
-35,885
| -11% | -$488K |
|
1325
Brink's
BCO
$4.62B
| $3.72M | ﹤0.01% |
61,224
+660
| +1% | +$39.7K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.